Home    Peptides    99%-Tirzepatide-10mg/vial

99%-Tirzepatide-10mg/vial

Tezetide is a new drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes (T2DM). The drug has also demonstrated efficacy in weight loss, leading to its off-label use as an obesity treatment. Tizepatide is a dual agonist of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulin polypeptide (GIP) receptors. The drug can significantly improve blood sugar control and weight loss in patients with T2DM, similar to GLP-1 drugs such as semaglutide.
Contact Us

Product Details

Mechanism of action:

It works to stimulate first- and second-phase insulin secretion, and reduces glucagon levels, both in a glucose-dependent manner. Tirzepatide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake, 4 and reduce body weight in patients with type 2 diabetes.

 

For Educational purposes only:
Diabetes is a chronic disease that can lead to many complications, and controlling glucose balance is essential. Incretin hormones are produced in the gut and are essential to maintaining glucose homeostasis. Their effects range from increasing insulin synthesis, insulin secretion, and glucose sensing and decreasing glucagon secretion to promote satiety and suppressing appetite. Tirzepatide is a first in class dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide (GIP) analog.Tirzepatide is a synthetic chemical structure based on the GIP sequence and consists of 39 amino acid peptides. Tirzepatide in mice studies, increases insulin secretion, reduces glucagon release in a glucose-dependent manner, decreases fasting and postprandial glucose levels, promotes satiety, decreases body weight, and delays gastric emptying. Pharmacodynamics and pharmacokinetics properties of tirzepatide were similar in mice with kidney and hepatic impairment, and its metabolites are excreting through urine and feces.

The Formula:

To figure out how many doses you can get out of each vial: (total mg of vial ÷ whatever your desired dosage is)= how many of those doses you can get out of a specific vial. (Note: this formula goes for all measurements when trying to figure out how many doses can be achieved out of any milligram vial.)

Example: 10mg (vial) ÷ 2.5mg (the dose I want)= 4

So 4 doses of 2.5mg is how many doses I can get out a 10mg vial.

Tirzepatide Doses:

2.5mg (the starter dose for beginner researchers) ; 3.5mg (custom dose if jumping up to 5mg is too strong); 5mg; 7.5mg, 10mg, 12.5mg; and 15mg

Semaglutide Doses:

.25mg; .50mg (the perfect dose for beginner researchers); 75mg; 1mg; 1.5mg; 1.7mg; 2mg; and 2.4mg